지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록· 키워드
오류제보하기
A single-blind comparative study was performed using haloperidol as a reference drug in order to evaluate the efficacy and safety of nemonapride, a new benzamide derivative, in sixty-nine Korean schizophrenic patients. the total period of the study was 8 weeks, maximum dosage of nemonapride was 36mg and that of haloperidol was 24mg. Psychopathology and extrapyramidal symptoms were assessed every week or four weeks until the end of the 8th week using the PANSS, BPRS, and 4 point general side effect check list, The drug safety was assessed every week until the end of the 8th week using vital sign, body weight, EEG, EKG, and blood chemistry. In total. one patient discontinued nemonapride treatment and seven patients discontinued haloperidol treatment before the end of the study. Therefore sixty-one patients(88 %) completed the study. PNASS and BPRS scores of the two groups on the end study point demonstrated a significant improvement compared with baseline score. The number of patients who had a clinical improvement of at least 20% in baseline score was similiar in both treatment groups. The difference of Simpson's rating scale socres were significant in both groups, and mean scores were more high in the haloperidol group than in nemonapride group. No significant EKG, EEG changes were induced, no relevant change in body weight or clinical laboratory parameters were observed in the sixty-one patients during 8 weeks and no Significant difference in the both groups. From these results, nemonapride is considered to be a clinically useful drug having a wide range of antipsychotic effect in schzophrenic patients.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
네모나프라이드의 유효성 및 추체외로 부작용 : Haloperidol 및 Risperidone과의 자연관찰적 개방형 비교연구
생물치료정신의학
2001 .12
-
Nemonapride 및 Olanzapine 투여 후 정신분열병 환자의 혈장 Homovanillic Acid 농도의 변동
생물치료정신의학
2002 .06
-
불응성 정신분열증환자의 Clozapine 치료효과
생물정신의학
1995 .01
-
A Longitudinal Study of Relation between Side-effects and Clinical Improvement in Schizophrenia: Is There a Neuro-metabolic Threshold for Second Generation Antipsychotics?
Clinical Psychopharmacology and Neuroscience
2013 .01
-
Amisulpride Switching in Schizophrenic Patients Who Showed Suboptimal Effect and/or Tolerability to Current Antipsychotics in a Naturalistic Setting: An Explorative Study
Clinical Psychopharmacology and Neuroscience
2016 .01
-
Switching Patients with Chronic Schizophrenia to Aripiprazole: the Improvement in Cognitive Function
Clinical Psychopharmacology and Neuroscience
2006 .01
-
정신보건센터의 주간 및 직업재활 프로그램에 등록한 정신분열병 환자의 연령군간 특성
신경정신의학
2004 .01
-
정신분열병의 급성 치료에서 리스페리돈과 할로페리돌의 치료 효과와 추체외로 부작용
생물치료정신의학
2000 .06
-
물리치료적용에 따른 일부 뇌졸중환자의 우울증 변화
대한물리치료학회지(JKPT)
2001 .01
-
치료저항 정신분열증 환자의 Clozapine 효과
생물치료정신의학
1998 .06
-
Decreased IL-1ra and NCAM-1/CD56 Serum Levels in Unmedicated Patients with Schizophrenia Before and After Antipsychotic Treatment
PSYCHIATRY INVESTIGATION
2018 .01
-
외상 후 스트레스 장애 동반 여부에 따른 정신분열병 환자의 임상증상과 치료효과의 비교 : 1년간의 전향적 추적연구
생물정신의학
2009 .01
-
정신분열증 환자 간호
대한간호
1968 .01
-
주의력 결핍 과잉 운동 장애 환자들의 약물치료 효과 및 Comorbidity에 관한 연구
영남의대학술지
1993 .01
-
Efficacy and Safety of Intra-articular Injections of Hyaluronic Acid Combined With Polydeoxyribonucleotide in the Treatment of Knee Osteoarthritis
Annals of Rehabilitation Medicine
2019 .01
-
응급구조(학)과 학생의 응급환자평가 교육 전,후 비교 및 술기 수행 능력에 미치는 영향
한국응급구조학회지
2009 .01
-
방사선 치료를 받는 유방암 환자의 가족지지와 성격이 삶의 질에 미치는 영향
대한방사선치료학회지
2002 .01
-
Effect of Antipsychotics on the Quality of Life of Schizophrenic Patients in Community Mental Health Centers : Conventional versus Atypical Antipsychotics
Clinical Psychopharmacology and Neuroscience
2004 .01
-
의사결정 틀을 이용한 만성 심부전 환자의 자기관리프로그램이 자기효능, 자기관리 이행에 미치는 효과
성인간호학회지
2004 .06
이 논문의 저자 정보
최근 본 자료
댓글(0)
0